Acute and late outcomes of transcatheter aortic valve implantation (Tavi) for the treatment of severe symptomatic aortic stenosis in patients at high- and low-surgical risk

Journal of Interventional Cardiology

Volumn 25, Issue 4, 2012, Pages 364-374

  Schymik, Gerhard ^a   Schröfel, Holger ^b   Schymik, Jan S ^c   Wondraschek, Rainer ^a   Süselbeck, Tim ^d   Kiefer, Rüdiger ^b   Balthasar, Veronika ^b   Luik, Armin ^a   Posival, Herbert ^b   Schmitt, Claus ^a  

^a Municipal Hospital Karlsruhe   (Germany)

^b Clinic for Cardiac Surgery Karlsruhe   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d University Medical Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART VALVE PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84864627017     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2012.00729.x     Document Type: Article

References (32)

1. Brown JM, O'Brien SM, Wu C, et al,. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009; 137: 82-90.
2. Cribier A, Eltchaninoff H, Tron C, et al,. Treatment of calcific aortic stenosis with the percutaneous heart valve. Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006; 47: 1214-1223.
3. Webb JG, Pasupati S, Humphries K, et al,. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-763. (Pubitemid 47255993)
4. Walther T, Simon P, Dewey T, et al,. Transapical minimally invasive aortic valve implantation: Multicenter experience. Circulation 2007; 116: I-240-I-245.
5. Piazza N, Grube E, Gerckens U, et al,. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
6. Leon MB, Smith CR, Mack M, et al,. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
7. Smith CR, Leon MB, Mack MJ, et al,. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
8. Ad N, Barnett SD, Speir AM,. The performance of the EuroSCORE and the Society of Thoracic Surgeons mortality risk score: The gender factor. Interact CardioVasc Thorac Surg 2007; 6: 192-195. (Pubitemid 46596944)
9. Grube E, Schuler G, Buellesfeld L, et al,. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve Prosthesis. Device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50: 69-76. (Pubitemid 46970878)
10. Schymik G, Schröfel H, Brodowski S, et al,. Results following commercial adoption of transcatheter heart valve implantation in a Community Cardiac Interventions Program. Circulation 2010; 122 e16. /DOI: (14 Jun 2010).
11. Rodés-Cabau J, Webb JG, Cheung A, et al,. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. Acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55 (11): 1080-1090.
12. Thomas M, Schymik G, Walther T, et al,. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry. A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122: 62-69.
13. Wendler O, Walther T, Nataf P, et al,. Trans-apical aortic valve implantation: Univariate and multivariate analyses of the early results from the SOURCE Registry. Eur J Cardiothorac Surg 2010; 38: 119-127.
14. Tamburino C, Capodanno D, Ramondo A, et al,. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123: 299-308.
15. Zahn R, Gerckens U, Grube E, et al,. Transcatheter aortic valve implantation: First results from a multicentre real-world registry. Eur Heart J 2011; 97 (11): 899-906.
16. Fried LP, Tangen CM, Walston J, et al,. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci 2001; 56: 134-135.
17. Freeman RV, Otto CM,. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111: 3316-3326. (Pubitemid 40875006)
18. Kempfert J, Lehmann S, Linke A, et al,. Transapical transcatheter off-pump aortic valve implantation. MMCTS 2010; 3939: 1-8.
19. Gurvitch R, Wood DA, Tay EL, et al,. Transcatheter aortic valve implantation. Durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010; 22: 1319-1327.
20. Thomas M, Schymik G, Walther T, et al,. 1-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry. The European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011 Jul 26; 124 (4):425-433. Epub 2011 Jul 11.
21. Kalavrouziotis D, Li D, Buth KJ, et al,. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: A retrospective cohort study. J Cardiothorac Surg 2009; 4: 32-39.
22. Iung B, Baron G, Butchart EG, et al,. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-1243. (Pubitemid 36834640)
23. Ferrari E, Tozzi P, Hurni M, et al,. Primary isolated aortic valve surgery in octogenarians. Eur J Cardiothorac Surg 2010; 38: 128-133.
24. Carnero-Alcázar M, Reguillo-Lacruz F, Alswies A, et al,. Short- and mid-term results for aortic valve replacement in octogenarians. Interact Cardio Vasc Thorac Surg 2010; 10: 549-554.
25. Leontyev S, Walther T, Borger MA, et al,. Aortic valve replacement in octogenarians: Utility of risk stratification with EuroSCORE. Ann Thorac Surg 2009; 87 (5): 1440-1445.
26. Grossi EA, Schwartz CF, Yu P-J, et al,. High-risk aortic valve replacement: Are the outcomes as bad as predicted? Ann Thorac Surg 2008; 85: 102-107. (Pubitemid 350265781)
27. Buellesfeld L, Wenaweser P, Gerckens U, et al,. Transcatheter aortic valve implantation: Predictors of procedural success-the Siegburg-Bern experience. Eur Heart J 2010; 31: 984-991.
28. Leon MB, Piazza N, Nikolsky E, et al,. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the Valve Academic Research Consortium. Eur Heart J 2011 Jan; 32 (2): 205-217. Epub 2011 Jan 6.
29. Rockwood K, Stadnyk K, MacKnight C, et al,. A brief clinical instrument to classify frailty in elderly people. Lancet 1999 Jan 16; 353 (9148): 205-206. (Pubitemid 29088034)
30. Gurvitch R, Toggweiler S, Willson AB, et al,. Outcomes and complications of transcatheter aortic valve replacement using a ballon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. EuroIntervention 2011; 41-48.
31. Buchanan GL, Chieffo A, Montorfano M, et al,. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN and Medtronic CoreValve ReValving system devices: The Milan registry. EuroIntervention 2011; 556-563.
32. Roques F, Nashef SA, Michel P, et al,. Risk factors and outcome in European cardiac surgery: Analysis of the EuroSCORE multinational database of 19,030 patients. Eur J Cardiothorac Surg 1999; 15 (6): 816-822.